Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul 19;13(14):2357.
doi: 10.3390/ani13142357.

The 3Rs in Experimental Liver Disease

Sebastian Martinez-Lopez  1   2 , Enrique Angel-Gomis  1   2 , Elisabet Sanchez-Ardid  3   4 , Alberto Pastor-Campos  5 , Joanna Picó  1 , Isabel Gomez-Hurtado  1   2   3
Affiliations
Review

The 3Rs in Experimental Liver Disease

Sebastian Martinez-Lopez et al. Animals (Basel). .

Abstract

Patients with cirrhosis present multiple physiological and immunological alterations that play a very important role in the development of clinically relevant secondary complications to the disease. Experimentation in animal models is essential to understand the pathogenesis of human diseases and, considering the high prevalence of liver disease worldwide, to understand the pathophysiology of disease progression and the molecular pathways involved, due to the complexity of the liver as an organ and its relationship with the rest of the organism. However, today there is a growing awareness about the sensitivity and suffering of animals, causing opposition to animal research among a minority in society and some scientists, but also about the attention to the welfare of laboratory animals since this has been built into regulations in most nations that conduct animal research. In 1959, Russell and Burch published the book "The Principles of Humane Experimental Technique", proposing that in those experiments where animals were necessary, everything possible should be done to try to replace them with non-sentient alternatives, to reduce to a minimum their number, and to refine experiments that are essential so that they caused the least amount of pain and distress. In this review, a comprehensive summary of the most widely used techniques to replace, reduce, and refine in experimental liver research is offered, to assess the advantages and weaknesses of available experimental liver disease models for researchers who are planning to perform animal studies in the near future.

Keywords: disease; liver; reduction; refinement; replacement; research.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Relevant human and mouse differences in liver physiopathology. Although mice remain one of the best approximations to the human systems, key differences in liver biology need to be considered while designing projects in order to avoid failed experiments and inconclusive results, thus meeting the 3Rs principles. With respect to liver anatomy, albeit the external appearance differs between mice and humans, the functional microscopic lobule architecture is quite conserved in both [28]. This aspect translates into similar phenotypic manifestations during liver pathology (steatosis, inflammation, and fibrosis), although the symptomatology of advanced human disease is difficult to mimic in mice [29]. This might be attributed to the differences in rodents’ local immune system and metabolism. Regarding liver immunology, mice are considered more tolerant, with a reduced response to bacterial products and potent regulatory lymphocytes compared to humans [30,31]. Metabolism is considered to be more active in murine models, being exemplified in the expansion of metabolic enzyme genes and their respective increased production [32,33]. Remarkably, these distinctions are further exemplified in omics analyses that highlight partially divergent genomic responses to liver injury and disease progression [34,35], ultimately indicating that improved models, such as humanized mice, could reduce the gap between the two species [36]. This image was created using Biorender platform.
See this image and copyright information in PMC

Similar articles

  • Replacement, reduction and refinement.
    Flecknell P. Flecknell P. ALTEX. 2002;19(2):73-8. ALTEX. 2002. PMID: 12098013
  • 60 Years of the 3Rs symposium: Lessons learned and the road ahead.
    Balls M, Bass R, Curren R, Fentem J, Goldberg A, Hartung T, Herrmann K, Kleinstreuer NC, Libowitz L, Parascandola J, Rowan A, Spielmann H, Stephens ML, Thomas RS, Tsaioun K. Balls M, et al. ALTEX. 2024;41(2):179-201. doi: 10.14573/altex.2403061. ALTEX. 2024. PMID: 38629803
  • Culture of Care: Organizational Responsibilities.
    Brown MJ, Symonowicz C, Medina LV, Bratcher NA, Buckmaster CA, Klein H, Anderson LC. Brown MJ, et al. In: Weichbrod RH, Thompson GA, Norton JN, editors. Management of Animal Care and Use Programs in Research, Education, and Testing. 2nd edition. Boca Raton (FL): CRC Press/Taylor & Francis; 2018. Chapter 2. In: Weichbrod RH, Thompson GA, Norton JN, editors. Management of Animal Care and Use Programs in Research, Education, and Testing. 2nd edition. Boca Raton (FL): CRC Press/Taylor & Francis; 2018. Chapter 2. PMID: 29787190 Free Books & Documents. Review.
  • Practical Application of the 3Rs in Rodent Transgenesis.
    Buch T, Jerchow B, Zevnik B. Buch T, et al. Methods Mol Biol. 2023;2631:33-51. doi: 10.1007/978-1-0716-2990-1_2. Methods Mol Biol. 2023. PMID: 36995663
  • Conceptual foundations for a clarified meaning of the 3Rs principles in animal experimentation.
    Louis-Maerten E, Rodriguez Perez C, Cajiga RM, Persson K, Elger BS. Louis-Maerten E, et al. Anim Welf. 2024 Sep 23;33:e37. doi: 10.1017/awf.2024.39. eCollection 2024. Anim Welf. 2024. PMID: 39347486 Free PMC article. Review.
See all similar articles

Cited by

References

    1. Driskill J.H., Pan D. The Hippo Pathway in Liver Homeostasis and Pathophysiology. Annu. Rev. Pathol. 2021;16:299–322. doi: 10.1146/annurev-pathol-030420-105050. - DOI - PMC - PubMed
    1. Schuppan D., Afdhal N.H. Liver cirrhosis. Lancet. 2008;371:838–851. doi: 10.1016/S0140-6736(08)60383-9. - DOI - PMC - PubMed
    1. Yanguas S.C., Cogliati B., Willebrords J., Maes M., Colle I., van den Bossche B., de Oliveira C., Andraus W., Alves V.A.F., Leclercq I., et al. Experimental models of liver fibrosis. Arch. Toxicol. 2016;90:1025–1048. doi: 10.1007/s00204-015-1543-4. - DOI - PMC - PubMed
    1. Bosch J., Pizcueta P., Feu F., Fernandez M., Garcia-Pagan J.C. Pathophysiology of portal hypertension. Gastroenterol. Clin. N. Am. 1992;21:1–14. doi: 10.1016/S0889-8553(21)00175-8. - DOI - PubMed
    1. Bataller R., Brenner D.A. Liver fibrosis. J. Clin. Investig. 2005;115:209–218. doi: 10.1172/JCI24282. - DOI - PMC - PubMed

Grants and funding

This research has been partially funded by Ministry of Sciences, Innovation and Universities, Ma-drid, Spain, grant number PID2019-107036RB-I00; and by Institute of Health Carlos III (ISCIII), grant number PMP21/00082 cofunded by European Union—Next GenerationEU and Recovery, Transformation and Resilience Plan.

LinkOut - more resources